Cargando…
Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation
Patients with eosinophilic asthma react well to conventional treatment of asthma while individualized therapy for non-eosinophilic endotypes have yet to be developed. Dysregulated sphingosine metabolites are associated with the pathophysiology of different asthma endotypes with their receptors invol...
Autores principales: | Wang, Shanshan, Tian, Zhen, Lu, Yanjiao, Huang, Zhenli, Fan, Yan, Li, Boyu, Zheng, Hongyan, Wu, Xiaojie, Wang, Meijia, Zhao, Jianping, Xie, Jungang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086758/ https://www.ncbi.nlm.nih.gov/pubmed/37056936 http://dx.doi.org/10.7150/ijbs.80256 |
Ejemplares similares
-
Pentraxin 3 promotes airway inflammation in experimental asthma
por: Gao, Pengfei, et al.
Publicado: (2020) -
Sphingosine 1-Phosphate Induces Neutrophil Chemoattractant IL-8: Repression by Steroids
por: Rahman, Md. Mostafizur, et al.
Publicado: (2014) -
Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma
por: Wang, Meijia, et al.
Publicado: (2016) -
Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study
por: Lu, Yanjiao, et al.
Publicado: (2021) -
Increased expression of ficolin-1 is associated with airway obstruction in asthma
por: Gao, Pengfei, et al.
Publicado: (2023)